Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Upgraded to “Strong-Buy” at Barclays

Barclays upgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) to a strong-buy rating in a research note published on Tuesday,Zacks.com reports.

A number of other equities analysts also recently commented on the stock. Jefferies Financial Group downgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “buy” rating to a “hold” rating in a research note on Monday, October 21st. UBS Group lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 19th. Finally, Berenberg Bank lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 25th.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Down 0.7 %

Shares of MURGY opened at $11.01 on Tuesday. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 52-week low of $8.40 and a 52-week high of $11.20. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.20. The stock has a fifty day simple moving average of $10.41 and a two-hundred day simple moving average of $10.36. The company has a market capitalization of $73.63 billion, a PE ratio of 7.16, a price-to-earnings-growth ratio of 1.73 and a beta of 1.02.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.